The path from the developed substance to the successful transdermal therapeutic system (TTS) or oral thin film (OTF) is a long and labour-intensive one. As such, you need a strong, experienced and commited partner at your side. LTS as the market leader fulfils all these requirements.

LTS leads the way globally in transdermal therapeutic systems LTS TTS and oral thin films LTS OTF.

With its partners from the pharmaceutical industry, LTS has developed the most TTS products onto the market. These transdermal patches make treatment much easier for a large number of patients.

LTS has the experience and expertise to develop and manufacture successful products right up to market approval.

LTS has sufficient capacity to manufacture the batch sizes required for global sales and high-volume products. Two identical production facilities in Andernach (Germany) and West Caldwell (USA) secure supply chain reliability even in crisis periods.

LTS has production capabilities of varying sizes to operate all demands from early drug development to large-scale production campaigns. As such, LTS matches its manufacturing processes for its products customer specific to the ideal equipment.

LTS is recognised by all major health authorities the world over.

LTS has broad experience in the field of hormone therapy and with anaesthetics narcotic substances. LTS systematically separates the production of hormone products from non-hormone products avoiding any risk of possible cross – contamination.

LTS offers all services from a single source – from feasibility studies and clinical trials (up to phase II) to production and packaging.
For more information, visit the CRS-Website!

LTS supports each client with its very own development team, which can also be integrated into a client´s research team comprising employees from the client company.

On the basis of mutual trust, LTS offers its customers complete transparency in all project phases.